Soberania farmacêutica no Brasil [Norberto Prestes, presidente da Abiquifi] – Futuro Talks #96

The Covid-19 pandemic exposed a weakness that had previously gone unnoticed by a large part of the population: Brazil's high dependence on imported inputs to produce medicines. Today, of the approximately 2,000 active pharmaceutical ingredients (APIs) registered with Anvisa (Brazilian Health Regulatory Agency), only between 120 and 150 are produced in the country. Since then, the discussion about sovereignty in health has gained prominence on the agenda regarding industrial health policy and sanitary safety. This is one of the topics discussed in the new episode of Futuro Talks, which featured Norberto Prestes, executive president of the Brazilian Association of Pharmaceutical Input Industries (Abiquifi). Watch the episode now! Futuro Talks is supported by Grupo Fleury, Roche, and Care Plus. -- Also visit: https://futurodasaude.com.br/   / futurodasaude   #FuturoTalks #FuturodaSaúde #Health #sovereignty #IFAs #medicines #NorbertoPrestes #Abiquifi